Approval · Notice of Compliance 12282 · 2011
ADVIL CAPLETS: Notice of Compliance 12282
Issued April 21, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12282
- Date
- April 21, 2011
- Company
- Pfizer Consumer Healthcare, a division of Pfizer Canada ULCMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Analgesic / Antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL CAPLETS | 01933531 | Marketed |
| ADVIL TABLETS | 01933558 | Marketed |
| ADVIL GEL CAPLETS | 02230541 | Cancelled Post Market |
| ADVIL EXTRA STRENGTH CAPLETS | 02244577 | Marketed |
| ADVIL MUSCLE AND JOINT | 02355701 | Marketed |